替罗非班在老年急性前循环大动脉闭塞性脑梗死机械取栓中的应用价值及患者短期预后
CSTR:
作者:
作者单位:

(1.邢台市中心医院 介入科,河北 邢台 054000;2.邢台市中心医院药剂科,河北 邢台 054000;3.邢台市中心医院神经内科,河北 邢台 054000)

作者简介:

通讯作者:

中图分类号:

基金项目:

邢台市市级科技计划自筹经费项目(2024ZC220)


Application value of tirofiban during mechanical thrombectomy and its effect on short-term prognosis in elderly patients with anterior circulation large artery occlusion-related acute cerebral infarction
Author:
Affiliation:

(1.Department of Interventional Medicine, Xingtai 054000, Hebei Province, China;2.Department of Pharmacy, Xingtai 054000, Hebei Province, China;3.Department of Neurology, Xingtai Central Hospital, Xingtai 054000, Hebei Province, China)

Fund Project:

This work wassupported by theXingtaiMunicipal Scienceand TechnologyPlanSelf-Financing Project(2024ZC220).

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 探讨老年急性前循环大动脉闭塞性脑梗死患者替罗非班联合机械取栓治疗后血管再通率及安全性,并分析影响患者短期预后的相关因素。方法 选择邢台市中心医院2022年12月至2024年3月收治的120例老年急性前循环大动脉闭塞性脑梗死患者为研究对象,根据患者是否应用替罗非班将其分为替罗非班组(替罗非班+机械取栓,n=67)和对照组(机械取栓,n=53),比较两组患者血管再通率、症状性颅内出血、治疗安全性及治疗后神经功能。术后随访90d,采用Rankin修订量表(mRS)评分评价两组患者预后情况(mRS≤2分为预后良好)。采用SPSS 26.0统计软件进行数据分析,根据数据类型组间比较分别行t检验或χ2检验。采用二元logistic回归模型分析影响患者预后的相关因素。结果 替罗非班组患者血管再通率高于对照组[85.07%(57/67)和67.92%(36/53)];术后90d mRS量表得分≤2分(预后状况良好)者占比高于对照组[80.60%(54/67)和(58.49%31/53)];治疗后7d美国国立卫生研究院卒中量表(NIHSS)评分低于对照组,差异均有统计学意义(P<0.05)。两组患者症状性颅内出血、再闭塞及住院期间死亡率比较,差异无统计学意义(P>0.05)。以患者术后90d预后状态作为因变量,行二元logistic回归分析提示,合并2型糖尿病(OR=2.109,95%CI 1.442~3.084)及基线NIHSS评分(OR=2.408,95%CI 1.713~3.387)是患者预后不良的危险因素(P<0.05);侧支循环分级3~4级(OR=0.359,95%CI 0.159~0.810)、联合替罗非班(OR=0.482,95%CI 0.296~0.786)及血管再通(OR=4.100,95%CI 2.069~8.126)是患者预后不良的保护因素(P<0.05)。结论 机械取栓联合替罗非班能有效提高老年急性前循环大动脉闭塞性脑梗死患者闭塞血管再通率,改善神经功能及预后,且不增加出血风险,联合替罗非班是患者术后短期预后不良的保护性因素。

    Abstract:

    Objective To explore the vascular recanalization rate and safety of tirofiban combined with mechanical thrombectomy in elderly patients with acute cerebral infarction due to anterior circulation large artery occlusion (AC-LAO), and analyze the related factors affecting the short-term prognosis of patients. Methods A total of 120 elderly eligible patients admitted to our hospital from December 2022 to March 2024 were enrolled, and according to whether tirofiban was used or not, they were divided into tirofiban group (tirofiban+mechanical thrombectomy, n=67) and control group (mechanical thrombectomy, n=53). The vascular recanalization rate, symptomatic intracranial hemorrhage, treatment safety and neurological function after treatment were compared between the two groups. In 90 d after follow-up, modified Rankin scale (mRS) was applied to assess the prognosis of patients (mRS score ≤2 points as good prognosis). Data analysis was performed by using SPSS statistics 26.0, and t test or Chi-square test was performed depending on data type. Binary logistic regression model was used to analyze the related factors affecting the prognosis. Results The tirofiban group had significantly higher vascular recanalization rate [85.07%(57/67) vs 67.92%(36/53)], larger proportion of mRS score ≤2 points (good prognosis status) at 90 d after surgery [80.60% (54/67)vs 58.49%(31/53)], and lower National Institutes of Health stroke scale (NIHSS) score at 7 d after treatment when compared with the control group (P<0.05). There were no statistical differences between the two groups in incidence of symptomatic intracranial hemorrhage, re-occlusion occurrence and mortality rate during hospitalization (P>0.05). Taking the prognostic status at 90 d after surgery as a dependent variable, binary logistic regression analysis indicated that concurrent type 2 diabetes mellitus (OR=2.109, 95%CI 1.442-3.084) and baseline NIHSS score (OR=2.408, 95%CI 1.713-3.387) were risk factors for poor prognosis, and collateral circulation grade 3-4 (OR=0.359, 95%CI 0.159-0.810), combination of tirofiban (OR=0.482, 95%CI 0.296-0.786) and vascular recanalization (OR=4.100, 95%CI 2.069-8.126) were protective factors for poor prognosis (P<0.05). Conclusion Mechanical thrombectomy combined with tirofiban can effectively enhance the vascular recanalization rate and improve the neurological function and prognosis in the elderly patients with acute cerebral infarction due to AC-LAO, and it does not increase the risk of hemorrhage. Combination of tirofiban is a protective factor for poor postoperative short-term prognosis.

    参考文献
    相似文献
    引证文献
引用本文

李春梅,刘静川,和长青,李志永.替罗非班在老年急性前循环大动脉闭塞性脑梗死机械取栓中的应用价值及患者短期预后[J].中华老年多器官疾病杂志,2025,24(12):917-921
DOI:10.11915/j. issn.1671-5403.2025.12.194

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2024-12-20
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-12-16
  • 出版日期:
文章二维码